REVASCULAR THERAPEUTICS
Revascular Therapeutics is a medical device company that develops solutions for the intravascular treatment of complex lesions and total occlusions. Revascular develops percutaneous medical devices to reopen occluded vessels.
REVASCULAR THERAPEUTICS
Industry:
Health Care Medical Device Therapeutics
Founded:
1999-01-01
Address:
Sunnyvale, California, United States
Country:
United States
Status:
Active
Total Funding:
10.24 M USD
Similar Organizations
Hybernia Medical
Hybernia Medical develops a cooling catheter system designed for the treatment of acute organ ischemia.
Current Employees Featured
Founder
Investors List
Adams Street Partners
Adams Street Partners investment in Series B - Revascular Therapeutics
Latterell Venture Partners
Latterell Venture Partners investment in Series B - Revascular Therapeutics
BioStar Capital
BioStar Capital investment in Series B - Revascular Therapeutics
Charter Life Sciences
Charter Life Sciences investment in Series B - Revascular Therapeutics
More informations about "Revascular Therapeutics"
Revascular Therapeutics - Crunchbase Company Profile & Funding
Revascular Therapeutics is a medical device company that develops solutions for the intravascular treatment of complex lesions and total occlusions. Revascular develops …See details»
Revascular Therapeutics - Funding, Financials, Valuation & Investors
Revascular Therapeutics develops solutions for the treatment of total occlusions in arteries.See details»
Revascular Therapeutics - Products, Competitors, Financials, …
ReVascular Therapeutics has pioneered advances in technology for the intravascular treatment of complex lesions and total occlusions that typically cannot be treated using current catheter …See details»
ReVascular Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore ReVascular Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Boston Scientific acquires two devices to treat CTOs
Feb 17, 2011 · Boston Scientific announced the acquisition of two technologies, a re-entry catheter from S.I. Therapies and an intraluminal CTO crossing device from ReVascular …See details»
Routine Revascularization Versus Initial Medical Therapy for Stable ...
Jun 26, 2020 · In patients with stable ischemic heart disease (SIHD), revascularization by either percutaneous coronary intervention (PCI) or coronary artery bypass graft surgery (CABG) plus …See details»
The revascular active percutaneous interventional device for …
Aug 1, 2008 · We sought to evaluate the efficacy and safety of the novel RVT CTO Guidewire Device (RVT-GDW, ReVascular Therapeutics, Sunnyvale, CA) in this complex scenario. …See details»
Current concepts in coronary artery revascularisation
In this Review, we evaluate the current evidence on coronary revascularisation with the aim of summarising key concepts to help to inform clinical decision making. We also highlight gaps in …See details»
The Long-Awaited Revascularization Guidelines Are Out: What’s In …
Dec 9, 2021 · For patients in shock or who are hemodynamically unstable, revascularization is recommended, irrespective of timing, with CABG indicated when PCI is not feasible. It is …See details»
Revascularization in stable coronary artery disease | The BMJ
Jun 13, 2022 · In this review we present and discuss the evidence supporting revascularization in stable CAD. The review is aimed at clinicians assessing patients with chest pain and coronary …See details»
ESC/EACTS Guidelines on Myocardial Revascularization
ESC Clinical Practice Guidelines aim to present all the relevant evidence to help physicians weigh the benefits and risks of a particular diagnostic or therapeutic procedure on Myocardial …See details»
The Long-Awaited Revascularization Guidelines Are Out: What’s In …
Revascular-ization is, in fact, afforded a Class 2a recommendation regarding reduction of cardiovascular events including spontaneous myocardial infarction, unplanned urgent …See details»
Overview of Revascularization for Acute Coronary Syndromes
Revascularization is the restoration of blood supply to ischemic myocardium in an effort to limit ongoing damage, reduce ventricular irritability, and improve short-term and long-term …See details»
Feature | Coronary Revascularization the Focus of New ACC/AHA …
Jan 1, 2022 · The 2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization addresses a broad range of topics including health equity, duration of dual antiplatelet therapy …See details»
Coronary Revascularization the Focus of New ACC/AHA Clinical …
Dec 9, 2021 · The newest clinical guideline from the ACC and American Heart Association, in partnership with the Society for Cardiovascular Angiography and Interventions, provides an …See details»
Revascularization for Renovascular Disease: A Scientific Statement …
Jun 16, 2022 · Renovascular disease refers to an occlusive vascular disease in arteries that perfuse one or both kidneys with attendant activation of pressor systems, sodium avidity, …See details»
Complete versus incomplete coronary revascularization ... - Nature
Oct 16, 2020 · Guideline-directed medical therapy is the foundation of treatment for all patients with CAD and can stabilize or regress coronary artery atherosclerotic plaques, preventing …See details»
2021 ACC/AHA/SCAI Guideline for Coronary Artery …
1.2 Organization of the Writing Committee. The writing committee consisted of clinicians, general cardiologists, interventional cardiologists, cardiac surgeons, a cardiac anesthesiologist, an …See details»
2021 ACC/AHA/SCAI Guideline for Coronary Artery …
Dec 9, 2021 · Recommendations from the earlier percutaneous coronary intervention and coronary artery bypass graft surgery guidelines have been updated with new evidence to …See details»
ACC/AHA/SCAI Coronary Revascularization Guideline: Key …
Dec 9, 2021 · Percutaneous revascularization is a reasonable option to improve survival, compared with medical therapy, in selected patients with low-to-medium anatomic complexity …See details»